PROTHENA CORPORATION PUBLIC LIMITED COMPANY Operating Lease Liability
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Operating Lease Liability of $6.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $6.99M.
- 2026-03-31: Operating Lease, Liability $7.65M.
- 2025-12-31: Operating Lease, Liability $8.37M.
- 2025-09-30: Operating Lease, Liability $9.08M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $6.99M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $7.65M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $8.37M 10-K · filed 2026-02-27 |
| 2025-09-30 | $9.08M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.78M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $10.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.84M 10-K · filed 2025-02-27 |
| 2024-09-30 | $11.49M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $12.12M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $12.50M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $10.73M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.45M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $4.88M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.47M 10-K · filed 2023-02-28 |
| 2022-09-30 | $8.03M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $9.58M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $10.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $12.33M 10-K · filed 2022-02-25 |
| 2021-09-30 | $13.75M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $15.15M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $16.50M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $17.84M 10-K · filed 2021-02-26 |
| 2020-09-30 | $19.16M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $20.45M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $21.70M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $22.94M 10-K · filed 2020-03-03 |
| 2019-09-30 | $24.16M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $25.36M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $26.51M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |